Literature DB >> 26755438

Impact of vision loss among survivors of childhood central nervous system astroglial tumors.

Peter M K de Blank1,2, Michael J Fisher3,4, Lu Lu5, Wendy M Leisenring6, Kirsten K Ness5, Charles A Sklar7, Marilyn Stovall8, Chris Vukadinovich5, Leslie L Robison5, Gregory T Armstrong5, Kevin R Krull5.   

Abstract

BACKGROUND: The impact of impaired vision on cognitive and psychosocial outcomes among long-term survivors of childhood low-grade gliomas has not been investigated previously but could inform therapeutic decision making.
METHODS: Data from the Childhood Cancer Survivor Study were used to investigate psychological outcomes (measures of cognitive/emotional function) and socioeconomic outcomes (education, income, employment, marital status, and independent living) among astroglial tumor survivors grouped by 1) vision without impairment, 2) vision with impairment (including unilateral blindness, visual field deficits, and amblyopia), or 3) bilateral blindness. The effect of vision status on outcomes was examined with multivariate logistic regression with adjustments for age, sex, cranial radiation therapy, and medical comorbidities.
RESULTS: Among 1233 survivors of childhood astroglial tumors 5 or more years after their diagnosis, 277 (22.5%) had visual impairment. In a multivariate analysis, survivors with bilateral blindness were more likely to be unmarried (adjusted odds ratio (OR), 4.7; 95% confidence interval [CI], 1.5-15.0), live with a caregiver (adjusted OR, 3.1; 95% CI, 1.3-7.5), and be unemployed (adjusted OR, 2.2; 95% CI, 1.1-4.5) in comparison with those without visual impairment. Bilateral blindness had no measurable effect on cognitive or emotional outcomes, and vision with impairment was not significantly associated with any psychological or socioeconomic outcomes.
CONCLUSIONS: Adult survivors of childhood astroglial tumors with bilateral blindness were more likely to live unmarried and dependently and to be unemployed. Survivors with visual impairment but some remaining vision did not differ significantly with respect to psychological function and socioeconomic status from those without visual impairment. Cancer 2016;122:730-739.
© 2016 American Cancer Society. © 2016 American Cancer Society.

Entities:  

Keywords:  childhood cancer survivors; optic pathway glioma; pediatric glioma late effects; vision loss

Mesh:

Substances:

Year:  2016        PMID: 26755438      PMCID: PMC4764436          DOI: 10.1002/cncr.29705

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  39 in total

1.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

2.  The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.

Authors:  Shelley L Hyman; Arthur Shores; Kathryn N North
Journal:  Neurology       Date:  2005-10-11       Impact factor: 9.910

3.  Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force.

Authors:  R Listernick; D N Louis; R J Packer; D H Gutmann
Journal:  Ann Neurol       Date:  1997-02       Impact factor: 10.422

4.  Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study.

Authors:  Patricia A Ganz; Katherine A Desmond; Beth Leedham; Julia H Rowland; Beth E Meyerowitz; Thomas R Belin
Journal:  J Natl Cancer Inst       Date:  2002-01-02       Impact factor: 13.506

5.  Ocular late effects in childhood and adolescent cancer survivors: a report from the childhood cancer survivor study.

Authors:  Kimberly F Whelan; Kayla Stratton; Toana Kawashima; John W Waterbor; Robert P Castleberry; Marilyn Stovall; Charles A Sklar; Roger J Packer; Pauline Mitby; Candice L Aitken; Julie Blatt; Leslie L Robison; Ann C Mertens
Journal:  Pediatr Blood Cancer       Date:  2010-01       Impact factor: 3.167

Review 6.  Gliomas of the optic nerve or chiasm. Outcome by patients' age, tumor site, and treatment.

Authors:  E C Alvord; S Lofton
Journal:  J Neurosurg       Date:  1988-01       Impact factor: 5.115

7.  Optic pathway gliomas in children with and without neurofibromatosis 1.

Authors:  Elzbieta Czyzyk; Sergiusz Jóźwiak; Marcin Roszkowski; Robert A Schwartz
Journal:  J Child Neurol       Date:  2003-07       Impact factor: 1.987

8.  Optic pathway gliomas in neurofibromatosis type 1: the effect of presenting symptoms on outcome.

Authors:  Allison King; Robert Listernick; Joel Charrow; Linda Piersall; David H Gutmann
Journal:  Am J Med Genet A       Date:  2003-10-01       Impact factor: 2.802

9.  Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project.

Authors:  Leslie L Robison; Ann C Mertens; John D Boice; Norman E Breslow; Sarah S Donaldson; Daniel M Green; Frederic P Li; Anna T Meadows; John J Mulvihill; Joseph P Neglia; Mark E Nesbit; Roger J Packer; John D Potter; Charles A Sklar; Malcolm A Smith; Marilyn Stovall; Louise C Strong; Yutaka Yasui; Lonnie K Zeltzer
Journal:  Med Pediatr Oncol       Date:  2002-04

10.  Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study.

Authors:  Roger J Packer; James G Gurney; Judy A Punyko; Sarah S Donaldson; Peter D Inskip; Marilyn Stovall; Yutaka Yasui; Ann C Mertens; Charles A Sklar; H Stacy Nicholson; Lonnie K Zeltzer; Joseph P Neglia; Leslie L Robison
Journal:  J Clin Oncol       Date:  2003-09-01       Impact factor: 50.717

View more
  14 in total

1.  Chronic Health Conditions and Neurocognitive Function in Aging Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study.

Authors:  Yin Ting Cheung; Tara M Brinkman; Chenghong Li; Yasmin Mzayek; Deokumar Srivastava; Kirsten K Ness; Sunita K Patel; Rebecca M Howell; Kevin C Oeffinger; Leslie L Robison; Gregory T Armstrong; Kevin R Krull
Journal:  J Natl Cancer Inst       Date:  2018-04-01       Impact factor: 13.506

Review 2.  Effects of Brain Tumors on Vision in Children.

Authors:  Jason H Peragallo
Journal:  Int Ophthalmol Clin       Date:  2018

Review 3.  Optic Pathway Gliomas in Neurofibromatosis Type 1: An Update: Surveillance, Treatment Indications, and Biomarkers of Vision.

Authors:  Peter M K de Blank; Michael J Fisher; Grant T Liu; David H Gutmann; Robert Listernick; Rosalie E Ferner; Robert A Avery
Journal:  J Neuroophthalmol       Date:  2017-09       Impact factor: 3.042

Review 4.  Psychological Symptoms, Social Outcomes, Socioeconomic Attainment, and Health Behaviors Among Survivors of Childhood Cancer: Current State of the Literature.

Authors:  Tara M Brinkman; Christopher J Recklitis; Gisela Michel; Martha A Grootenhuis; James L Klosky
Journal:  J Clin Oncol       Date:  2018-06-06       Impact factor: 44.544

5.  Ophthalmological Findings in Youths With a Newly Diagnosed Brain Tumor.

Authors:  Myrthe A Nuijts; Inge Stegeman; Tom van Seeters; Marloes D Borst; Carlien A M Bennebroek; Dennis R Buis; Nicole C Naus; Giorgio L Porro; Michelle B van Egmond-Ebbeling; Elisabeth S M Voskuil-Kerkhof; JanWillem R Pott; Niels E Franke; Evelien de Vos-Kerkhof; Eelco W Hoving; Antoinette Y N Schouten-van Meeteren; Saskia M Imhof
Journal:  JAMA Ophthalmol       Date:  2022-10-01       Impact factor: 8.253

6.  Identifying causal relationships of cancer treatment and long-term health effects among 5-year survivors of childhood cancer in Southern Sweden.

Authors:  Anders Holst; Jan Ekman; Magnus Petersson-Ahrholt; Thomas Relander; Thomas Wiebe; Helena M Linge
Journal:  Commun Med (Lond)       Date:  2022-03-02

7.  Social attainment in survivors of pediatric central nervous system tumors: a systematic review and meta-analysis from the Children's Oncology Group.

Authors:  Fiona Schulte; Alicia S Kunin-Batson; Barbara A Olson-Bullis; Pia Banerjee; Matthew C Hocking; Laura Janzen; Lisa S Kahalley; Hayley Wroot; Caitlin Forbes; Kevin R Krull
Journal:  J Cancer Surviv       Date:  2019-10-17       Impact factor: 4.442

Review 8.  Neuro-Oncology Practice Clinical Debate: targeted therapy vs conventional chemotherapy in pediatric low-grade glioma.

Authors:  Tabitha Cooney; Kee Kiat Yeo; Cassie Kline; Michael Prados; Daphne Haas-Kogan; Susan Chi; Sabine Mueller
Journal:  Neurooncol Pract       Date:  2019-08-13

Review 9.  Neurosurgical experience of managing optic pathway gliomas.

Authors:  Ciaran Scott Hill; Mehdi Khan; Kim Phipps; Katherine Green; Darren Hargrave; Kristian Aquilina
Journal:  Childs Nerv Syst       Date:  2021-02-03       Impact factor: 1.475

10.  Neuropsychological outcomes of children with Optic Pathway Glioma.

Authors:  Chiara Papini; Robert A Dineen; David A Walker; Shery Thomas; Nicola J Pitchford
Journal:  Sci Rep       Date:  2020-02-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.